why choose us

First received: March 16, 2023

Clinical Trial: RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hematopoietic and Lymphoid System Neoplasm

Study Type: INTERVENTIONAL


Official Title: A Pilot Prospective Study of the RefleXion [18F]- FDG PET-CT Subsystem Imaging Performance in Patients With Various Malignancies

Brief Summary: This clinical trial examines RefleXion Medical Radiotherapy System (RMRS) imaging to the standard of care (SOC) fludeoxyglucose F-18 ([18F]-FDG)- positron emission tomography (PET)-computed tomography (CT) imaging in patients with various cancers (malignancies).PET is an established imaging technique that utilizes small amounts of radioactivity attached to very minimal amounts of tracer, in the case of this research, [18F]-FDG.Because some cancers take up [18F]-FDG, cancer cells can be seen with PET.CT utilizes…

Read more